HOUSTON, TX Oct. 28, 2008. Pharm-Olam International (POI) a multi-national, full service CRO to the pharmaceutical and biotech industries announces the formation of a Rescue Start-up Team (RST) to assist sponsors with challenging ongoing studies.
“Many CROs have a specialist team to start-up planned studies, but rescue work requires a different strategy to meet tight deadlines and recover lost time. The RST strategy was formalized from our experiences rescuing multiple studies in the last two years”, said Iain Gordon, Vice President of Commercial and Corporate Affairs.
The RST quickly analyzes options for enrollment including: additional countries, new sites within existing countries, and assessing active sites with potential for improvement. After assessment, the plan is initiated by specialists who work in parallel to achieve regulatory approval, site agreements and logistical requirements for the study.
“Pharm-Olam has started a few rescue studies with the RST formally in place and we have averaged a three week reduction from the time we are awarded work to the first site initiation visit”, said Gordon. “We have more than 40 countries to choose from when we implement a rescue plan. From India to Argentina and from South Africa to Romania we can provide options with suitable regulatory environments and patient availability for almost every trial.”
POI provided supplemental enrollment for more studies between 2007 and 2008 than in any previous year, recruiting patients in over 25 countries including India, Poland, Serbia, Mexico, USA and Romania.
For more information please contact firstname.lastname@example.org
About Pharm-Olam International
Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.